Skip to main content
Premium Trial:

Request an Annual Quote

Aclara and Iceland Genomics Collaborate on Protein-Biomarker Study

NEW YORK, Dec. 2 (GenomeWeb News) - Iceland Genomics and Aclara BioSciences will collaborate on a cancer biomarker study, the companies said today.


Aclara will use its eTag technology to assay tumor and blood samples from cancer patients and from blinded patient data that contain treatment histories and outcomes, collected by Iceland Genomics. Aclara will also pay an undisclosed sum to Iceland Genomics, which will incorporate the data from the study into its database.


The research will evaluate proteins and protein complex and functional or activation states in cell-signaling pathways, the companies said.


Aclara is  slated to be acquired by ViroLogic sometime before January.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.